A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery

Archives of Orthopaedic and Trauma Surgery

Volumn 127, Issue 8, 2007, Pages 665-670

  Abad, J Ignacio ^a   Gómez Outes, Antonio ^b   Martínez González, Javier ^b   Rocha, Eduardo ^c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Bemiparin; Deep vein thrombosis; Heparin; Hip replacement; Knee replacement; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

BEMIPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BLEEDING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMARTHROSIS; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HIP DISEASE; HOSPITALIZATION; HUMAN; INJECTION SITE REACTION; KNEE ARTHROPLASTY; KNEE DISEASE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN BRUISING; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS; URTICARIA; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; LENGTH OF STAY; MALE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 34548166531     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-006-0239-x     Document Type: Article

References (24)

1. Beattie WS, Badner NH, Choi P (2001) Epidural analgesia reduces postoperative myocardial infarction: A meta-analysis. Anesth Analg 93:853-858
2. Black N (2001) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218
3. Bounameaux H, Perneger T (2002) Fondaparinux: A new pentasaccharide for thrombosis prevention. Lancet 359:1710-1711
4. Chapman TM, Goa KL (2003) Bemiparin: A review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis. Drugs 63:2357-2377
5. Dahl OE, Caprini JA, Colwell CW Jr, Frostick SP, Haas S, Hull RD, Laporte S, Stein PD (2005) Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost 93:860-866
6. Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials. Lancet 358:9-15
7. Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators (2003) Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: A multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 163:1337-1342
8. Fenollosa J, Seminario P (2001) Eficacia y seguridad de bemiparina en la profilaxis del tromboembolismo venoso en cirugía ortopédica. Rev Ortop Traumatol 6:460-465
9. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: The 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S-400S
10. Honorato J, Gómez-Outes A, Navarro-Quilis A, Martínez-González J, Rocha E, Planès A (2004) Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery. Pharmacoeconomics 22:885-894
11. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS (2003) Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 28:172-197
12. Kakkar VV, Howes J, Sharma V, Kadziola Z (2000) A comparative, double-blind, randomized trial of a new second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment Group. Thromb Haemost 83:523-529
13. Lowe GD, Sandercock PA, Rosendaal FR (2003) Prevention of venous thromboembolism after major orthopaedic surgery: Is fondaparinux an advance?. Lancet 362:504-505
14. Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A (2003) Efficacy and safety of Bemiparin compared with Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty. A randomized double-blind clinical trial. J Thromb Haemost 1:425-432
15. Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A; Cardiovascular Disease Educational, Research Trust, the International Union of Angiology (2001) Prevention of venous thromboembolism international consensus statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20:1-37
16. Planes A (2003) Review on bemiparin sodium - a new second generation low-molecular-weight heparin - and its applications in venous thromboembolism. Expert Opin Pharmacother 4:1551-1561
17. Raskob GE, Hirsh J (2003) Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopaedic surgery. Chest 124:379S-385S
18. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, Sage D, Futter M, Saville G, Clark T, MacMahon S (2000) Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ 321:1493-1497
19. Silbersack Y, Taute BM, Hein W, Podhaisky H (2004) Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 86:809-812
20. Strebel N, Prins M, Agnelli G, Buller HR (2002) Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 162:1451-1456
21. Tryba M (1998) European practice guidelines: Thromboembolism prophylaxis and regional anesthesia. Reg Anesth Pain Med 23(2 Suppl):178-182
22. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: A meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162:1833-1840
23. Westrich GH, Haas SB, Mosca P, Peterson M (2000) Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Surg Br 82-B:795-800
24. Zufferey P, Laporte S, Quenet S, Molliex S, Auboyer C, Decousus H, Mismetti P (2003) Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trials. Thromb Haemost 90:654-661